DALRYMPLE & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Defense authorization and appropriations legislation, MILVAX Program, Biodefense and biological product acquisition and R&D issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | PRINCIPAL |
Health Issues HCR
Project BioShield, Biodefense vaccine and biological product R&D, procurement for the Strategic National Stockpile, and product liability related oversight, authorizing, and appropriations legislation; DHHS and CDC procurement of anthrax vaccines
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | PRINCIPAL |
Homeland Security HOM
Project BioShield and bioterrorism preparedness authorization and appropriatons legislation and related oversight issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | PRINCIPAL |
Medical/Disease Research/Clinical Labs MED
Biodefense R&D Vaccine and Biological Product funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD DALRYMPLE | PRINCIPAL |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.